ETHEX Corporation Issues Nationwide Voluntary Recall o...( ST. LOUIS Jan. 28 /- ETHEX Corpor...)

ST. LOUIS, Jan. 28 /PRNewswire-FirstCall/ -- ETHEX Corporation, a subsidiary of KV Pharmaceutical (NYSE: KVa/KVb), is issuing, as previously disclosed by KV Pharmaceutical Company on January 26, 2009, a nationwide voluntary recall of the products identified below (all lots within their expiration dates) at a wholesale or a retail level as a precautionary measure because they may have been manufactured under conditions that did not sufficiently comply with current Good Manufacturing Practices (cGMPs). Some of these products have had specific lots recalled earlier due to defects found, including oversized tablets delivering higher than labeled doses. These additional products are being removed to assure that no other defective products remain in the marketplace.

Patients who may have these medicines in their possession should continue to take them in accordance with their prescriptions, as the risk of suddenly stopping needed medication may place patients at risk. Patients should contact their physician or healthcare provider if they have experienced any problems that may be related to taking or using these products, or to obtain replacement medications or prescriptions.

    Products Recalled to WHOLESALE Level:

    Amlodipine Besylate Tablets, 10mg (58177-538-26 & 538-11)
    Amlodipine Besylate Tablets, 2.5mg (58177-536-26)
    Amlodipine Besylate Tablets, 5mg (58177-537-26, 537-07 & 537-11)
    Benazepril HCl Tablets, 10mg (58177-342-04 & 342-08)
    Benazepril HCl Tablets, 20mg (58177-343-04 & 343-08)
    Benazepril HCl Tablets, 40mg, (58177-344-04 & 344-08)
    Benazepril HCl Tablets, 5mg (58177-341-04)
    Benzonatate Capsules, 100mg (58177-091-04 & 091-08)
    Benzonatate Capsules, 200mg (58177-092-04 & 092-08)
    Bromfenex ER Capsules (58177-019-04)
    Bromfenex PD ER Capsules (58177-020-04)
    Buspirone HCl Tablets, 10mg (58177-265-04 & 265-08)
    Buspir
'/>"/>
SOURCE  KV Pharmaceutical
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 
Related biology technology :

1. ETHEX Corporation Voluntarily Recalls Specific Lots of 30 mg. and 60 mg. Morphine Sulfate Extended Release Tablets Due to the Potential for Oversized Tablets
2. Memry Corporation Announces Preliminary Fiscal Fourth Quarter and 2007 Revenue
3. PeriCor Therapeutics Announces Closing of Licensing Agreement for Acadesine with Schering-Plough Corporation
4. AGA Medical Corporation Receives FDA and CE Mark Approvals for the AMPLATZER Vascular Plug II
5. Drug Royalty Corporation (DRC) Announces Acquisition Regarding PEG-INTRON(R) From Enzon Pharmaceuticals, Inc. (ENZN)
6. BioElectronics Corporation Announces Singapore and Malaysia Sales
7. Avicena Signs Worldwide Exclusive Distribution Agreement with RITA Corporation for its Proprietary Dermaceutical Compounds
8. DURECT Corporation to Present at the NewsMakers in the Biotech Industry Investment Conference
9. Insulet Corporation to Present at the Thomas Weisel Partners Healthcare Conference on September 6, 2007
10. Luminex Corporation to Present at Thomas Weisel Partners Healthcare Conference
11. Verenium Corporation to Present at the Upcoming Cowen and Company Clean Energy Conference